318 related articles for article (PubMed ID: 17122237)
21. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch.
Gandhi SD; Weiskopf RB; Jungheinrich C; Koorn R; Miller D; Shangraw RE; Prough DS; Baus D; Bepperling F; Warltier DC
Anesthesiology; 2007 Jun; 106(6):1120-7. PubMed ID: 17525586
[TBL] [Abstract][Full Text] [Related]
22. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
23. [Thrombelastographic coagulation analysis following in vitro and in vivo haemodilution with hydroxyethyl starch (HES)].
Asskali F; Lehmann G; Förster H
Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 May; 37(5):258-66. PubMed ID: 12015682
[TBL] [Abstract][Full Text] [Related]
24. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.
Morelli VM; de Visser MC; van Tilburg NH; Vos HL; Eikenboom JC; Rosendaal FR; Bertina RM
Thromb Haemost; 2007 Apr; 97(4):534-41. PubMed ID: 17393014
[TBL] [Abstract][Full Text] [Related]
25. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
Treib J; Haass A; Pindur G; Seyfert UT; Treib W; Grauer MT; Jung F; Wenzel E; Schimrigk K
Thromb Haemost; 1995 Dec; 74(6):1452-6. PubMed ID: 8772219
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
[TBL] [Abstract][Full Text] [Related]
27. Familial clustering of factor VIII and von Willebrand factor levels.
Kamphuisen PW; Houwing-Duistermaat JJ; van Houwelingen HC; Eikenboom JC; Bertina RM; Rosendaal FR
Thromb Haemost; 1998 Feb; 79(2):323-7. PubMed ID: 9493584
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary function is better preserved in pigs when acute normovolemic hemodilution is achieved with hydroxyethyl starch versus lactated Ringer's solution.
Margarido CB; Margarido NF; Otsuki DA; Fantoni DT; Marumo CK; Kitahara FR; Magalhães AA; Pasqualucci CA; Auler JO
Shock; 2007 Apr; 27(4):390-6. PubMed ID: 17414421
[TBL] [Abstract][Full Text] [Related]
29. Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van Vliet HH
Acta Haematol; 2009; 121(2-3):85-97. PubMed ID: 19506353
[TBL] [Abstract][Full Text] [Related]
30. [Changes in coagulation physiology and rheology after preoperative normovolemic hemodilution].
Hensel M; Wrobel R; Volk T; Pahlig H; Kox WJ
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Oct; 31(8):481-7. PubMed ID: 9019177
[TBL] [Abstract][Full Text] [Related]
31. Renal effects of hypotensive anaesthesia in combination with acute normovolaemic haemodilution with hydroxyethyl starch 130/0.4 or isotonic saline.
Fenger-Eriksen C; Hartig Rasmussen C; Kappel Jensen T; Anker-Møller E; Heslop J; Frøkiaer J; Tønnesen E
Acta Anaesthesiol Scand; 2005 Aug; 49(7):969-74. PubMed ID: 16045658
[TBL] [Abstract][Full Text] [Related]
32. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials.
Kozek-Langenecker SA; Jungheinrich C; Sauermann W; Van der Linden P
Anesth Analg; 2008 Aug; 107(2):382-90. PubMed ID: 18633012
[TBL] [Abstract][Full Text] [Related]
33. Effect of high- and low-molecular-weight low-substituted hydroxyethyl starch on blood coagulation during acute normovolemic hemodilution in pigs.
Thyes C; Madjdpour C; Frascarolo P; Buclin T; Bürki M; Fisch A; Burmeister MA; Asmis L; Spahn DR
Anesthesiology; 2006 Dec; 105(6):1228-37. PubMed ID: 17122586
[TBL] [Abstract][Full Text] [Related]
34. The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A.
Vlot AJ; Mauser-Bunschoten EP; Zarkova AG; Haan E; Kruitwagen CL; Sixma JJ; van den Berg HM
Thromb Haemost; 2000 Jan; 83(1):65-9. PubMed ID: 10669157
[TBL] [Abstract][Full Text] [Related]
35. Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects.
de Jonge E; Levi M; Büller HR; Berends F; Kesecioglu J
Intensive Care Med; 2001 Nov; 27(11):1825-9. PubMed ID: 11810130
[TBL] [Abstract][Full Text] [Related]
36. The effect of 6% hydroxyethyl starch and desmopressin infusion on von Willebrand factor: ristocetin cofactor activity.
Lazarchick J; Conroy JM
Ann Clin Lab Sci; 1995; 25(4):306-9. PubMed ID: 7545380
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of crystalloids and hydroxyethyl starch during normovolemic hemodilution. A study of hemodynamics and saturation measurement].
Falchi S; Adembri C; Marinelli L; Tani R; Novelli GP
Minerva Anestesiol; 1992 Apr; 58(4):145-9. PubMed ID: 1377806
[TBL] [Abstract][Full Text] [Related]
38. The significance of evaluating conventional inflammatory markers in Von Willebrand factor measurement.
Lippi G; Franchini M; Targher G; Poli G; Guidi GC
Clin Chim Acta; 2007 Jun; 381(2):167-70. PubMed ID: 17433810
[TBL] [Abstract][Full Text] [Related]
39. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.
Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B
Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712
[TBL] [Abstract][Full Text] [Related]
40. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction.
O'Donnell J; Tuddenham EG; Manning R; Kemball-Cook G; Johnson D; Laffan M
Thromb Haemost; 1997 May; 77(5):825-8. PubMed ID: 9184386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
